Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Will Receive Nasdaq Delisting Warning if Shares Close Below $1 Today

NEW YORK, Sept. 15 (GenomeWeb News) - Sequenom will receive a delisting warning letter from the Nasdaq exchange if the company's share price closes below $1 today.

 

Sequenom's shares have been trading below $1 for the last 29 days, closing at $.89 yesterday. Nasdaq sends out delisting warning letters whenever a company's stock fails to keep the closing price of its shares at or above $1 for 30 consecutive trading days.

 

This is not the first time that Sequenom comes close to a Nasdaq warning. In December, the company missed a warning letter by a single day, and came similarly close in September of 2004.

 

Yesterday, the company said it will will lay off around 30 percent of its workforce, or 44 staffers, in a large-scale restructuring aimed at cutting costs and redirecting resources.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.